Abstract 3845: Anti-tumor potential of Hydralazine, a DNMT1 inhibitor, on breast cancer growth and progression

Authors: Parth B. Patel

Published: 2019-08-07

DOI: 10.1158/1538-7445.am2019-3845

Source: Full article

Abstract

Abstract